• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Mol Med (Berl) . Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19

tetano

Editor, Senior Moderator
J Mol Med (Berl)


. 2022 Mar 26.
doi: 10.1007/s00109-022-02190-7. Online ahead of print.
Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19


Noemi Veraldi[SUP] 1 [/SUP], Romain R Vivès[SUP] 2 [/SUP], Géraldine Blanchard-Rohner[SUP] 3 4 [/SUP], Arnaud G L'Huillier[SUP] 5 6 [/SUP], Noemie Wagner[SUP] 6 [/SUP], Marie Rohr[SUP] 6 [/SUP], Maurice Beghetti[SUP] 7 [/SUP], Ariane De Agostini[SUP] 8 [/SUP], Serge Grazioli[SUP] 9 [/SUP]



Affiliations

Abstract

Multisystem inflammatory syndrome in children (MIS-C) represents a rare but severe complication of severe acute respiratory syndrome coronavirus 2 infection affecting children that can lead to myocardial injury and shock. Vascular endothelial dysfunction has been suggested to be a common complicating factor in patients with coronavirus disease 2019 (COVID-19). This study aims to characterize endothelial glycocalyx degradation in children admitted with MIS-C. We collected blood and urine samples and measured proinflammatory cytokines, myocardial injury markers, and endothelial glycocalyx markers in 17 children admitted with MIS-C, ten of which presented with inflammatory shock requiring intensive care admission and hemodynamic support with vasopressors. All MIS-C patients presented signs of glycocalyx deterioration with elevated levels of syndecan-1 in blood and both heparan sulfate and chondroitin sulfate in the urine. The degree of glycocalyx shedding correlated with tumor necrosis factor-α concentration. Five healthy age-matched children served as controls. Patients with MIS-C presented severe alteration of the endothelial glycocalyx that was associated with disease severity. Future studies should clarify if glycocalyx biomarkers could effectively be predictive indicators for the development of complications in adult patients with severe COVID-19 and children with MIS-C. KEY MESSAGES : Children admitted with MIS-C presented signs of endothelial glycocalyx injury with elevated syndecan-1 and heparan sulfate level. Syndecan-1 levels were associated with MIS-C severity and correlated TNF-α concentration. Syndecan-1 and heparan sulfate may represent potential biomarkers for patients with severe COVID-19 or MIS-C.

Keywords: COVID-19; Endothelium; Glycocalyx; Heparan sulfate; Inflammation; MIS-C.
 
Back
Top Bottom